Courtney Hanson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Courtney Hanson has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Afrina Brishti
Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58202, USA
1 shared publication - Brenna M. Espelien
Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58202, USA
1 shared publication - Brett A. McGregor
Department of Biomedical Sciences School of Medicine and Health Sciences University of North Dakota Grand Forks North Dakota USA
1 shared publication - David S. Bradley
Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58202, USA
1 shared publication - James E. Porter
Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, United States
1 shared publication - Julia Bs Kockanowski
Department of Pathology, UND School of Medicine and Health Sciences, Grand Forks, ND
1 shared publication
Latest Publications
- Open Access
- 11 March 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 149
Acquired ventricular septal defect secondary to aortic valve endocarditis
Infective endocarditis remains a deadly disease with a significant mortality rate. While ventricular septal defects (VSDs) have been linked to an increased risk of infective endocarditis, cases of acquired VSDs resulting from infective endocarditis are not well-documented in the literature. Our report highlights a rare case of acquired VSD that resulted directly from aortic valve endocarditis, treated with successful repair and placement of permanent pacemaker.
- 11 March 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 149
Open AccessAcquired ventricular septal defect secondary to aortic valve endocarditis
Infective endocarditis remains a deadly disease with a significant mortality rate. While ventricular septal defects (VSDs) have been linked to an increased risk of infective endocarditis, cases of acquired VSDs resulting from infective endocarditis are not well-documented in the literature. Our report highlights a rare case of acquired VSD that resulted directly from aortic valve endocarditis, treated with successful repair and placement of permanent pacemaker.
- Open Access
- 22 October 2024
- Published by Springer Nature in Research Square
Acquired Ventricular Septal Defect Secondary to Aortic Valve Endocarditis
Introduction: Infective endocarditis remains a deadly disease with an in-hospital mortality rate of around 20%. While ventricular septal defects (VSDs) have been linked to an increased risk of infective endocarditis, cases of acquired VSDs resulting from infective endocarditis are not well-documented in the literature. Our report highlights a rare case of acquired VSD that resulted directly from aortic valve endocarditis. Case Presentation: A 57-year-old male presented to an outside hospital with chest pain, shortness of breath, and low-grade fevers for the past seven days. Additionally, poor dentition was noted. Blood cultures detected gram-positive staphylococci and streptococcus anginosus. Due to concern for endocarditis, an order was placed for both a transthoracic echocardiogram (TTE) and transesophageal echocardiogram (TEE). Results showed aortic regurgitation, stenosis, and a mobile growth. The patient was managed with IV antibiotics until transferred. Upon arrival at our facility, TEE revealed a VSD that demonstrated left-to-right flow into the right ventricle. Due to the risk of cardiac decompensation and septic embolization, immediate surgical intervention was necessary. The aorta was opened, and the diseased aortic valve was excised. The necrotic septum was debrided and an acquired VSD the size of a quarter was identified. A pericardial patch was used to repair the VSD. Following debridement a mechanical aortic valve was placed. The patient was taken to ICU in a stable condition. However, several days following the procedure, the patient developed ongoing arrhythmia, and a permanent pacemaker was placed. Conclusions: It has been well-documented in literature that congenital VSDs are associated with an increased incidence of endocarditis. However, only a few cases have been documented where a VSD results directly from aortic valve endocarditis. This is the first recorded case of an adult in the U.S. with native aortic valve gram-positive staphylococci and streptococcus anginosus endocarditis resulting in a large acquired VSD. The condition was successfully diagnosed and treated with surgery. Successful treatment of post-operative arrhythmia with permanent pacemaker placement was achieved- a first for acquired VSD caused by infectious endocarditis.
- 22 October 2024
- Published by Springer Nature in Research Square
Open AccessAcquired Ventricular Septal Defect Secondary to Aortic Valve Endocarditis
Introduction: Infective endocarditis remains a deadly disease with an in-hospital mortality rate of around 20%. While ventricular septal defects (VSDs) have been linked to an increased risk of infective endocarditis, cases of acquired VSDs resulting from infective endocarditis are not well-documented in the literature. Our report highlights a rare case of acquired VSD that resulted directly from aortic valve endocarditis. Case Presentation: A 57-year-old male presented to an outside hospital with chest pain, shortness of breath, and low-grade fevers for the past seven days. Additionally, poor dentition was noted. Blood cultures detected gram-positive staphylococci and streptococcus anginosus. Due to concern for endocarditis, an order was placed for both a transthoracic echocardiogram (TTE) and transesophageal echocardiogram (TEE). Results showed aortic regurgitation, stenosis, and a mobile growth. The patient was managed with IV antibiotics until transferred. Upon arrival at our facility, TEE revealed a VSD that demonstrated left-to-right flow into the right ventricle. Due to the risk of cardiac decompensation and septic embolization, immediate surgical intervention was necessary. The aorta was opened, and the diseased aortic valve was excised. The necrotic septum was debrided and an acquired VSD the size of a quarter was identified. A pericardial patch was used to repair the VSD. Following debridement a mechanical aortic valve was placed. The patient was taken to ICU in a stable condition. However, several days following the procedure, the patient developed ongoing arrhythmia, and a permanent pacemaker was placed. Conclusions: It has been well-documented in literature that congenital VSDs are associated with an increased incidence of endocarditis. However, only a few cases have been documented where a VSD results directly from aortic valve endocarditis. This is the first recorded case of an adult in the U.S. with native aortic valve gram-positive staphylococci and streptococcus anginosus endocarditis resulting in a large acquired VSD. The condition was successfully diagnosed and treated with surgery. Successful treatment of post-operative arrhythmia with permanent pacemaker placement was achieved- a first for acquired VSD caused by infectious endocarditis.
- Open Access
- 4 August 2023
- Published by Wolters Kluwer Health in American Journal of Forensic Medicine & Pathology
- Vol. 44 (4) , 354-357
Acute Organophosphate Poisoning Case Review With Consideration of Off-Gassing During Postmortem Examination
Although self-harm via ingestion of organophosphorus compounds is relatively common in the developing world, it is rare in the United States. This article reviews the signs and symptoms associated with acute organophosphate poisoning and highlights the effects of organophosphate off-gassing during postmortem examinations to increase awareness of this potentially dangerous workplace exposure. Paramedics responded to a 42-year-old man with pulseless electrical activity. Spontaneous circulation was restored after aggressive resuscitation. Before loss of consciousness, the patient exhibited diaphoresis, vomiting, and diarrhea. Upon admission, the patient had a Glasgow Coma Scale score of 3. Significant laboratory values included a pH of 6.8, pco 2 of 72 mm Hg, and lactic acid of 21.8 mmol/L. Electrocardiography suggested inferior ST-elevation myocardial infarction. Electroencephalogram revealed severe cerebral dysfunction. The patient died shortly thereafter. Scene investigation revealed suicidal ideations, which included a snapshot of a bottle containing granular sediment associated with statements that he had imbibed fertilizer. During the postmortem examination, the decedent exuded a petroleum-like odor. In addition, autopsy personnel developed symptoms consistent with organophosphate exposure. A reported history of suspected organophosphate exposure in a decedent should prompt increased safety practices to avoid potential harm to autopsy personnel.
- 4 August 2023
- Published by Wolters Kluwer Health in American Journal of Forensic Medicine & Pathology
- Vol. 44 (4) , 354-357
Open AccessAcute Organophosphate Poisoning Case Review With Consideration of Off-Gassing During Postmortem Examination
Although self-harm via ingestion of organophosphorus compounds is relatively common in the developing world, it is rare in the United States. This article reviews the signs and symptoms associated with acute organophosphate poisoning and highlights the effects of organophosphate off-gassing during postmortem examinations to increase awareness of this potentially dangerous workplace exposure. Paramedics responded to a 42-year-old man with pulseless electrical activity. Spontaneous circulation was restored after aggressive resuscitation. Before loss of consciousness, the patient exhibited diaphoresis, vomiting, and diarrhea. Upon admission, the patient had a Glasgow Coma Scale score of 3. Significant laboratory values included a pH of 6.8, pco 2 of 72 mm Hg, and lactic acid of 21.8 mmol/L. Electrocardiography suggested inferior ST-elevation myocardial infarction. Electroencephalogram revealed severe cerebral dysfunction. The patient died shortly thereafter. Scene investigation revealed suicidal ideations, which included a snapshot of a bottle containing granular sediment associated with statements that he had imbibed fertilizer. During the postmortem examination, the decedent exuded a petroleum-like odor. In addition, autopsy personnel developed symptoms consistent with organophosphate exposure. A reported history of suspected organophosphate exposure in a decedent should prompt increased safety practices to avoid potential harm to autopsy personnel.
- Open Access
Modulation of Inflammatory Signaling Molecules in Bordetella pertussis Antigen-Challenged Human Monocytes in Presence of Adrenergic Agonists
BscF is a type III secretion system (T3SS) needle protein from Bordetella pertussis and has previously been shown to induce a sufficient Th1 and Th17 response in human monocytes and mice as a prerequisite for long-lasting protective immunity against pertussis infection. In our current study, we aim to compare the modulation of inflammatory signaling molecules as a direct measure of the immune response to the B. pertussis antigens BscF and Tdap in the presence or absence of the adrenergic receptor agonists phenylephrine (PE) or isoproterenol (ISO) to observe differences that may contribute to the diminished protective immunity of the current acellular pertussis (aP) vaccine, Tdap. Stimulation of human monocyte THP-1 cells with LPS, BscF, and Tdap induced a robust elevation of CCL20, CXCL10, PGE2, and PGF2α among most chemokine and prostanoid members when compared with the control treatment. Treatment with the adrenergic agonist PE or ISO significantly enhanced the BscF- and Tdap-stimulated modulation of CCL20 and CXCL10 but not PGE2 and PGF2α, suggesting that adrenergic modulation of pertussis antigen responses might be a new therapeutic strategy to improve the longevity of pertussis immunity. Stimulation of THP-1 cells with BscF alone initiated significant expression of CXCL10 and PGF2α but not when Tdap was used, suggesting that BscF might be an important pertussis antigen for next-generation pertussis vaccines or when combined with the current aP vaccine. Our data offer opportunities for designing new therapeutic approaches against pertussis infection.
Open AccessModulation of Inflammatory Signaling Molecules in Bordetella pertussis Antigen-Challenged Human Monocytes in Presence of Adrenergic Agonists
BscF is a type III secretion system (T3SS) needle protein from Bordetella pertussis and has previously been shown to induce a sufficient Th1 and Th17 response in human monocytes and mice as a prerequisite for long-lasting protective immunity against pertussis infection. In our current study, we aim to compare the modulation of inflammatory signaling molecules as a direct measure of the immune response to the B. pertussis antigens BscF and Tdap in the presence or absence of the adrenergic receptor agonists phenylephrine (PE) or isoproterenol (ISO) to observe differences that may contribute to the diminished protective immunity of the current acellular pertussis (aP) vaccine, Tdap. Stimulation of human monocyte THP-1 cells with LPS, BscF, and Tdap induced a robust elevation of CCL20, CXCL10, PGE2, and PGF2α among most chemokine and prostanoid members when compared with the control treatment. Treatment with the adrenergic agonist PE or ISO significantly enhanced the BscF- and Tdap-stimulated modulation of CCL20 and CXCL10 but not PGE2 and PGF2α, suggesting that adrenergic modulation of pertussis antigen responses might be a new therapeutic strategy to improve the longevity of pertussis immunity. Stimulation of THP-1 cells with BscF alone initiated significant expression of CXCL10 and PGF2α but not when Tdap was used, suggesting that BscF might be an important pertussis antigen for next-generation pertussis vaccines or when combined with the current aP vaccine. Our data offer opportunities for designing new therapeutic approaches against pertussis infection.